AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
Tag: KRAS inhibitors
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...